Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2001 1
2002 1
2004 3
2005 1
2006 3
2007 4
2008 3
2009 11
2010 1
2011 1
2012 5
2013 3
2014 4
2015 3
2016 2
2017 2
2018 2
2019 2
2020 1
2021 2
2022 2
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
European Forum on Antiphospholipid Antibodies: research in progress.
Meroni PL, Tincani A, Alarcón-Riquelme ME, Shoenfeld Y, Borghi MO. Meroni PL, et al. Lupus. 2009 Sep;18(10):924-9. doi: 10.1177/0961203309106916. Lupus. 2009. PMID: 19671794 Review.
The research projects of the European Forum on Antiphospholipid Antibodies are representative of how dynamic is this area of investigation. The present review is focused on the most recent projects of the Forum on the aetiopathogenic aspects of the …
The research projects of the European Forum on Antiphospholipid Antibodies are representative of how dynamic is this ar …
When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review.
Bejjani A, Khairani CD, Assi A, Piazza G, Sadeghipour P, Talasaz AH, Fanikos J, Connors JM, Siegal DM, Barnes GD, Martin KA, Angiolillo DJ, Kleindorfer D, Monreal M, Jimenez D, Middeldorp S, Elkind MSV, Ruff CT, Goldhaber SZ, Krumholz HM, Mehran R, Cushman M, Eikelboom JW, Lip GYH, Weitz JI, Lopes RD, Bikdeli B. Bejjani A, et al. J Am Coll Cardiol. 2024 Jan 23;83(3):444-465. doi: 10.1016/j.jacc.2023.10.038. J Am Coll Cardiol. 2024. PMID: 38233019 Review.
However, randomized controlled trials suggest that DOACs may not be as efficacious or as safe as the current standard of care in conditions such as mechanical heart valves, thrombotic antiphospholipid syndrome, and atrial fibrillation associated with rheumatic heart diseas …
However, randomized controlled trials suggest that DOACs may not be as efficacious or as safe as the current standard of care in conditions …
Summary of the 12th Meeting of the European Forum on antiphospholipid antibodies ONLINE.
Djokovic A, Stojanovich L. Djokovic A, et al. Lupus. 2021 Nov;30(13):2162-2164. doi: 10.1177/09612033211055010. Epub 2021 Oct 25. Lupus. 2021. PMID: 34696636
As a result of the current COVID-19 pandemic, the 12th meeting of the European Forum on Antiphospholipid Antibodies was held in a digital format on 26th March 2021. ...This report summarizes major studies and new research projects presented during the online …
As a result of the current COVID-19 pandemic, the 12th meeting of the European Forum on Antiphospholipid Antibodies was …
Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies.
Tincani A, Allegri F, Balestrieri G, Reber G, Sanmarco M, Meroni P, Boffa MC. Tincani A, et al. Thromb Res. 2004;114(5-6):553-8. doi: 10.1016/j.thromres.2004.06.035. Thromb Res. 2004. PMID: 15507291 Review.
Antiphospholipid ELISAs are part of the Antiphospholipid Antibodies Syndrome classification criteria, having the same diagnostic value as lupus anticoagulant. ...A collaborative study involving 36 European centres proved that the use of monoclonal anti-beta2
Antiphospholipid ELISAs are part of the Antiphospholipid Antibodies Syndrome classification criteria, having the same diagnost
The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 247 consecutive cases.
Alijotas-Reig J, Ferrer-Oliveras R, Ruffatti A, Tincani A, Lefkou E, Bertero MT, Coloma-Bazan E, de Carolis S, Espinosa G, Rovere-Querini P, Kuzenko A, Valverde EE, Robles A, Cervera R, Canti V, Fredi M, Gil-Aguado A, Lundelin K, Llurba E, Melnychuk T, Nalli C, Picardo E, Silvestro E, del Ross T, Farran-Codina I; (EUROAPS Study Group Collaborators). Alijotas-Reig J, et al. Autoimmun Rev. 2015 May;14(5):387-95. doi: 10.1016/j.autrev.2014.12.010. Epub 2014 Dec 31. Autoimmun Rev. 2015. PMID: 25555817 Review.
AIM: To analyse the clinical features, laboratory data, foetal-maternal outcomes, and follow-up in a cohort of 247 women with obstetric antiphospholipid syndrome (OAPS). METHODS: The European Registry on APS became a Registry within the framework of the European
AIM: To analyse the clinical features, laboratory data, foetal-maternal outcomes, and follow-up in a cohort of 247 women with obstetric a
European Forum On Antiphospholipid Antibodies: brief history report and governance document.
Cervera R. Cervera R. Lupus. 2012 Jun;21(7):699-703. doi: 10.1177/0961203312436865. Lupus. 2012. PMID: 22635206
The European Forum on Antiphospholipid Antibodies was conceived as a multidisciplinary network of different specialists working in the fields of internal medicine, haematology, rheumatology, obstetrics and gynaecology, neurology, paediatrics, cardiology and i …
The European Forum on Antiphospholipid Antibodies was conceived as a multidisciplinary network of different specialists …
54 results